The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Valley Fever Market Across 2026–2030?

The valley fever market size has experienced strong growth in recent years. It is projected to expand from $1.05 billion in 2025 to $1.1 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.4%. The historical increase in this market can be attributed to factors such as enhanced clinical recognition of fungal infections, the existence of established antifungal medications, a rise in reported cases within endemic areas, increased diagnostic testing, and the expansion of infectious disease treatment centers.

The market for valley fever is projected to experience substantial growth over the next few years. It is expected to achieve a valuation of $1.35 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.1%. This expansion during the forecast period can be linked to an increasing focus on rapid diagnostic tools, greater investment in novel antifungal therapies, the broadening of disease surveillance programs, heightened awareness regarding climate-related disease spread, and a rising demand for effective long-term treatment options. Significant trends expected in this period include an intensified focus on early diagnosis and treatment, the growing adoption of antifungal drug therapies, increased awareness in endemic regions, the expansion of combination treatment approaches, and escalating research into fungal disease management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22166&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Valley Fever Market?

The rising exposure to fungus spores is expected to propel the valley fever market going forward. Fungus spores are microscopic reproductive units produced by fungi that can spread through air, water, or surfaces, enabling the fungus to grow and reproduce in new environments. The exposure to fungus spores is increasing due to deforestation and changing weather patterns, which disturb soil and promote spore release, resulting to a higher risk of infections such as valley fever, especially in arid regions where the coccidioides fungus thrives. Valley fever treatment helps patients exposed to fungal spores by reducing symptoms, preventing complications, and controlling fungal growth, ultimately improving recovery and quality of life. For instance, in September 2024, according to the International Society for Infectious Diseases, a US-based non-profit organization, each year, invasive fungal infections impact about 6.5 million individuals, resulting in nearly 3.8 million fatalities, of which approximately 2.5 million are directly attributed to these infections. Therefore, the rising exposure to fungus spores is driving the growth of the valley fever market.

Valley Fever Market Driver: Expansion Of Healthcare Facilities Driving The Growth Of The Market Due To Advancements In Medical Technology

What Segmentation Levels Are Considered In The Valley Fever Market?

The valley fever market covered in this report is segmented –

1) By Types Of Treatment: Fluconazole, Itraconazole, Voriconazole, Posaconazole, Others Types Of Treatment

2) By Site Of Infection: Skin, Lungs, Liver, Bones, Heart, Brain, Membranes That Surround The Brain And Spinal Cord, Other Sites Of Infection

3) By End-Users: Human, Cattle, Sheep And Goats, Camel, Other End-Users

Subsegments:

1) By Fluconazole Type: Oral Fluconazole, Intravenous Fluconazole

2) By Itraconazole Type: Capsule Itraconazole, Oral Solution Itraconazole

3) By Voriconazole Type: Oral Voriconazole, Intravenous Voriconazole

4) By Posaconazole Type: Oral Suspension Posaconazole, Delayed-Release Tablets Posaconazole, Intravenous Posaconazole

5) By Other Treatment Types: Combination Therapy, Adjunctive Therapy

What Industry Trends Are Redefining The Valley Fever Market?

Leading companies in the valley fever market are prioritizing the creation of innovative vaccines for valley fever to counter the growing risk of fungal infections. Valley fever vaccines seek to safeguard individuals by utilizing advanced scientific and manufacturing processes, thereby boosting public health and safety. For instance, in August 2024, Anivive Lifesciences Inc., a US-based pet pharmaceutical company, secured a contract valued at up to $33 million from the National Institute of Allergy and Infectious Diseases (NIAID), a US-based government agency, specifically for the development of a human Valley Fever vaccine. This funding will facilitate supplementary manufacturing, formulation efforts, comprehensive safety testing, and a Phase 1 clinical trial, with the ultimate objective of providing the first vaccine to prevent a serious systemic fungal infection.

Which Leading Firms Are Contributing To The Growth Of The Valley Fever Market?

Major companies operating in the valley fever market are Merck & Co Inc, Fresenius Kabi, Dr Reddys Laboratories, Mankind Pharma, Atom Pharma, Cerata Pharmaceuticals, Pfizer Inc, Novartis AG, Sanofi S A, GlaxoSmithKline plc, Bayer AG, Astellas Pharma Inc, Abbott Laboratories Inc, SCYNEXIS Inc, Leadiant Biosciences Inc, Amplyx Pharmaceuticals Inc, Johnson & Johnson, Bristol Myers Squibb, Gilead Sciences Inc, Viatris Inc, Teva Pharmaceuticals USA Inc

Read the full valley fever market report here:

https://www.thebusinessresearchcompany.com/report/valley-fever-global-market-report

Which Regions Are Projected To Dominate The Valley Fever Market In The Coming Years?

North America was the largest region in the valley fever market in 2025. The regions covered in the valley fever market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Valley Fever Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22166&type=smp

Browse Through More Reports Similar to the Global Valley Fever Market 2026, By The Business Research Company

Ai Based Fever Detection Camera Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-based-fever-detection-camera-global-market-report

Influenza Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

Influenza Diagnostic Global Market Report

https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model